Why the study?
Does the addition of a beta-blocker to thiazide therapy reduce angiotensin II-dependent blood pressure and suppress the renin-angiotensin system in patients with essential hypertension?
Does the addition of a beta-blocker to thiazide therapy reduce angiotensin II-dependent blood pressure and suppress the renin-angiotensin system in patients with essential hypertension?
The addition of a beta-blocker to thiazide therapy suppresses the thiazide-induced stimulation of the renin-angiotensin system and eliminates the angiotensin II-dependence of blood pressure, contributing to its antihypertensive effect.
Answers are grounded in this paper and cite their sources.
Supports adjunctive beta-blocker use with thiazides to suppress RAS; extends mechanistic observations but remains hypothesis-generating.
Sixteen patients (11 male, five female), median age 41 years, with essential hypertension insufficiently controlled by hydrochlorothiazide (75 mg/day; diastolic blood pressure greater than or equal to 100 mmHg), were studied. 2. Plasma renin concentration [renin], plasma angiotensin II concentration ([ANG II]), plasma volume and exchangeable sodium (NaE) were determined, and a saralasin infusion (5.4 nmol min-1 kg-1) was carried out while the patients were on thiazide alone and, in 14 cases, 3 months after addition of a beta-adrenoreceptor blocker (propranolol, six, metoprolol, six, and atenolol, two patients). 3. On thiazide alone, saralasin caused a significant decrease in mean arterial blood pressure in 12 out of 16 patients. The saralasin response was closely related to pre-saralasin plasma [ANG II] (r = 0.73, P less than 0.01). Plasma [renin] and [ANG II] were higher than normal in the group as a whole. 4. After addition of a beta-adrenoreceptor blocker systolic and diastolic blood pressure decreased from 164/109 mmHg to 136/94 mmHg. Plasma [renin] and [ANG II] decreased by 40 and 58% respectively. At this point, saralasin caused no significant change in mean arterial pressure. No close correlation was found between plasma [renin] or [ANG II] or saralasin response on thiazide treatment and changes in blood pressure during subsequent thiazide/beta-adrenoreceptor-blocker treatment. Plasma volume and NaE did not change significantly. 5. In patients with thiazide-induced stimulation of the renin-angiotensin system, addition of a beta-adrenoreceptor blocker leads to suppression of the system and, at the same time, ANG II-dependence of blood pressure disappears. This contributes to the antihypertensive effect of beta-adrenoreceptor blockers in this particular situation.
No takes yet. Share an insight, caveat, or question.
Ibsen et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: